ACE2 and COVID-19: Evidence from mouse models of SARS suggests that ACE2 levels are reduced upon infection, with ACE2 knockout resulting in reduced cardiac contractility (Nishiga et al., 2020); however, whether this occurs in COVID-19 is unknown.